Literature DB >> 15201595

Relationship of psoriatic arthritis with the other spondyloarthropathies.

Philip S Helliwell1.   

Abstract

PURPOSE OF REVIEW: The seronegative spondyloarthropathies are a group of disorders sharing common clinical features, the hallmark of which is sacroiliitis. Despite the 40 years since psoriatic arthritis was recognized, controversy still exists about which patients to include within this disease group and the relation of psoriatic arthritis with the other spondyloarthropathies. RECENT
FINDINGS: Early disease can present difficulties because it is inappropriate to use criteria developed on established cases in early arthritis, in which many cases may be initially undifferentiated. The taxonomy of juvenile spondyloarthropathy remains a contentious issue, and further modifications of the Durban criteria have been suggested. The predictive value of the European Spondyloarthropathy Study Group criteria for spondyloarthropathy varies with the prevalence of the disease in the population under consideration, as has been demonstrated in ambulatory practice in France and Spain. It appears that physicians differ in their interpretation of the individual features, particularly of such clinical items as asymmetry and predominantly lower limb involvement. The combination of dactylitis of a toe, heel pain, and oligoarthritis appears to be strongly suggestive of psoriatic arthritis. However, solitary heel pain can be problematic, and ultrasonographic entheseal erosion at the calcaneum has been shown equally in rheumatoid arthritis and psoriatic arthritis. MRI may be more sensitive and quantitatively discriminative in psoriatic arthritis. Spinal involvement in psoriatic arthritis can be asymptomatic, as in classical ankylosing spondylitis. Importantly, psoriatic spondylitis has been observed in the absence of sacroiliitis.
SUMMARY: Clinicians generally agree that psoriatic arthritis constitutes a discreet subset within the spondyloarthropathy group, but the demarcation continues to be the subject of clinical research. The matter is confounded by the lack of agreed classification criteria for psoriatic arthritis; although in both adult and juvenile disease criteria for spondyloarthropathy exist, the place of psoriatic arthritis within this larger group requires further definition.

Entities:  

Mesh:

Year:  2004        PMID: 15201595     DOI: 10.1097/01.bor.0000129717.19777.9d

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  8 in total

Review 1.  Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis.

Authors:  William J Taylor; Philip C Robinson
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

Review 2.  Juvenile Spondyloarthropathies.

Authors:  Amra Adrovic; Kenan Barut; Sezgin Sahin; Ozgur Kasapcopur
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

3.  Sacroiliac joint involvement in psoriasis.

Authors:  Cahit Kaçar; Ilhan Sezer; Hilal Kocabaş; Hasan Fatih Cay; Can Cevikol; Erkan Alpsoy; Meltem Alkan Melikoğlu; Ayşe Akman
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

4.  Gastrointestinal comorbidities in patients with psoriatic arthritis.

Authors:  Ariel Zohar; Arnon Dov Cohen; Haim Bitterman; Ilan Feldhamer; Sari Greenberg-Dotan; Idit Lavi; Doron Comanesther; Erez Batat; Devy Zisman
Journal:  Clin Rheumatol       Date:  2016-08-17       Impact factor: 2.980

5.  Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis.

Authors:  P S Helliwell; G Porter; W J Taylor
Journal:  Ann Rheum Dis       Date:  2006-07-13       Impact factor: 19.103

6.  Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.

Authors:  B Vander Cruyssen; I E A Hoffman; H Zmierczak; M Van den Berghe; E Kruithof; L De Rycke; H Mielants; E M Veys; D Baeten; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

7.  Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis.

Authors:  Nermeen S A Abdel Fattah; Hanan E Hassan; Zenab A Galal; El Sayed E El Okda
Journal:  BMC Res Notes       Date:  2009-03-19

8.  Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative.

Authors:  Shawn Rose; Jenny Dave; Corina Millo; Haley B Naik; Evan L Siegel; Nehal N Mehta
Journal:  Arthritis Res Ther       Date:  2014-07-30       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.